Bausch + Lomb Corporation has announced the publication of results from a phase 3 study on LUMIFY® Preservative Free Redness Reliever Eye Drops in the journal Ophthalmology and Therapy. The study evaluated the efficacy and safety of the preservative-free formulation compared to the original LUMIFY eye drops in reducing ocular redness. Conducted with 380 participants, the trial demonstrated that LUMIFY Preservative Free is statistically non-inferior to LUMIFY in reducing redness, with a similar safety profile. The results suggest LUMIFY Preservative Free as a well-tolerated option for individuals with sensitivities to preservatives. Additional information is available on the LUMIFY website.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。